Remove Doctors Remove Pharmaceuticals Remove Prevention Remove Regulations
article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. According to the FDA’s website , here are some regulations: Ads must be truthful.

article thumbnail

GLP-1 Revolution, Non-Traditional Delivery, and Telehealth Expansion

HIT Consultant

The Centers for Disease Control and Prevention estimates that obesity accounts for $147 billion in annual healthcare costs, an amount which could be greatly lowered through use of the new drugs. But that will almost certainly happen as more pharmaceutical companies enter this market and the economies of scale take hold.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthy Data Management: How IT Assists Healthcare Institutions

HIT Consultant

Doctors remotely manage patient data without being tied to a specific medical facility. Confidentiality Laws and regulations govern the confidentiality of medical data. In Europe, this is GDPR (General Data Protection Regulation), in America, it’s HIPAA (Health Insurance Portability and Accountability Act).

article thumbnail

How the Powerful Forces of COVID-19 Changed the Healthcare Industry

HIT Consultant

Suddenly doctors’ offices were closed to patients, hospital emergency departments and ICUs were running out of beds, and healthcare workers were battling a new and unknown disease. When office visits became impossible, doctors shifted their business model almost overnight to offer patients virtual appointments.

article thumbnail

Legal and Ethical Analysis of Court-Ordered Ivermectin Treatment for COVID-19

Bill Of Health

Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) , that ivermectin is not an appropriate treatment, as it has been shown not to work against COVID. Must a hospital administer prescriptions requested by the patient but written by doctors not on the designated clinical care team?

Doctors 145
article thumbnail

Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype

Bill Of Health

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. NeĹźe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

article thumbnail

A Precautionary Approach to Touch in Psychedelic-Assisted Therapy

Bill Of Health

In the emerging psychedelics industry, the institutions and actors that require oversight and regulation are positioning themselves as regulators. She works to advance best practice prevention and evidence based institutional policies for sexual harm. Buisson and Ms.